Botulinum Toxin-A Injections Into Neurogenic Overactive Bladder-To Include or Exclude the Trigone? A Prospective, Randomized, Controlled Trial

被引:58
作者
Abdel-Meguid, Taha A. [1 ,2 ]
机构
[1] King Abdulaziz Univ Med City, Dept Urol, Jeddah, Saudi Arabia
[2] Menia Univ, Dept Urol, El Minia, Egypt
关键词
urinary bladder; neurogenic; spinal cord injuries; botulinum toxin type A; urinary incontinence; urodynamics; IDIOPATHIC DETRUSOR OVERACTIVITY; INTRADETRUSOR INJECTIONS; INCONTINENCE; STANDARDIZATION; TERMINOLOGY;
D O I
10.1016/j.juro.2010.08.028
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The short-term outcomes of initial detrusor injections vs combined detrusor-trigone botulinum toxin-A injections were determined in patients with spinal cord injury-neurogenic detrusor overactivity. Materials and Methods: Adults with refractory spinal cord injury-neurogenic detrusor overactivity who strictly discontinued anticholinergics were recruited for the study. At a 1: 1 ratio patients randomly received 300 U botulinum toxin-A intradetrusor injections excluding the trigone (detrusor arm) or 200 U intradetrusor plus 100 U intratrigonal injections (combined arm). Study end points were determination of the impact on incontinence episodes, complete dryness, quality of life, reusing anticholinergics, maximum detrusor pressure, reflex volume, maximum cystometric capacity, vesicoureteral reflux and adverse events. Patients were evaluated at baseline, and 2, 8, 12 and 18 weeks after injection. Statistical significance was considered at p<0.05. Results: Analysis included 18 patients per arm with no significant baseline differences. On within group analysis all parameters improved significantly compared to baseline. On between group analysis in the detrusor vs the combined arm at week 8 incontinence decreased by 52.4% vs 80.9% (number needed to treat 1.91 vs 1.23 patients, p<0.001), complete dryness was achieved in 33.3% vs 66.7% of patients (number needed to treat 3 vs 1.5, p<0.001) and quality of life score was decreased by 46.76% vs 48.13% (number needed to treat 2.14 vs 2.08, p<0.44). The absolute difference was 60% vs 82.5% for reflex volume (p<0.001), 66.2% vs 68.4% for maximum cystometric capacity (p<0.22) and -42.3% vs -41.9% for maximum detrusor pressure (p<0.21). At week 18 anticholinergics were needed again in 9 (50%) and 4 patients (22.2%) patients, respectively. No patient showed new or upgraded vesicoureteral reflux or reported significant adverse events. Conclusions: In the short term all parameters improved significantly in each arm. The superiority of including rather than excluding the trigone was significant.
引用
收藏
页码:2423 / 2428
页数:6
相关论文
共 45 条
  • [21] The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trial
    Dowson, C.
    Sahai, A.
    Watkins, J.
    Dasgupta, P.
    Khan, M. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (06) : 698 - 704
  • [22] Using a checklist to increase the effectiveness of behavioral therapy for overactive bladder: A prospective randomized controlled trial
    Kilinc, Muhammet F.
    Doluoglu, Omer G.
    Yildiz, Yildiray
    Yuceturk, Cem N.
    Hascicek, Ahmet M.
    NEUROUROLOGY AND URODYNAMICS, 2019, 38 (04) : 1152 - 1159
  • [23] Subcutaneous botulinum toxin type A injections for provoked vestibulodynia: a randomized placebo-controlled trial and exploratory subanalysis
    Inessa Diomande
    Natalie Gabriel
    Maki Kashiwagi
    Gian-Piero Ghisu
    JoEllen Welter
    Daniel Fink
    Mathias K. Fehr
    Cornelia Betschart
    Archives of Gynecology and Obstetrics, 2019, 299 : 993 - 1000
  • [24] Subcutaneous botulinum toxin type A injections for provoked vestibulodynia: a randomized placebo-controlled trial and exploratory subanalysis
    Diomande, Inessa
    Gabriel, Natalie
    Kashiwagi, Maki
    Ghisu, Gian-Piero
    Welter, JoEllen
    Fink, Daniel
    Fehr, Mathias K.
    Betschart, Cornelia
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 299 (04) : 993 - 1000
  • [25] Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
    Gong, Qin-Qin
    Xu, Yu-Qiong
    Xu, Jun
    Ding, Xiao-Yan
    Guo, Chong
    FRONTIERS IN PHARMACOLOGY, 2020, 10
  • [26] Electrical Stimulation of the Posterior Tibialis Nerve Improves Symptoms of Poststroke Neurogenic Overactive Bladder in Men: A Randomized Controlled Trial
    Monteiro, Ebe Santos
    Coin de Carvalho, Luciane Bizari
    Fukujima, Marcia Maiumi
    Lora, Mayra Ivanoff
    do Prado, Gilmar Fernandes
    UROLOGY, 2014, 84 (03) : 509 - 514
  • [27] Efficacy and Safety of Mirabegron Compared to Solifenacin in Treatment of Non-neurogenic Overactive Bladder in Children: A Randomized Controlled Trial
    Mansour, Islam
    Laymon, Mahmoud
    Abdelhalim, Ahmed
    Dawaba, Mohamed S.
    El-Hefnawy, Ahmed S.
    INTERNATIONAL BRAZ J UROL, 2025, 51 (02):
  • [28] Evaluating the effects of ice application on the pain felt during botulinum toxin type-A injections - A prospective, randomized, single-blind controlled trial
    Sarifakioglu, N
    Sarifakioglu, E
    ANNALS OF PLASTIC SURGERY, 2004, 53 (06) : 543 - 546
  • [29] Posterior tibial nerve stimulation as a neuromodulation therapy in treatment of neurogenic overactive bladder in multiple sclerosis: A prospective randomized controlled study
    Marzouk, Mohamed H.
    Darwish, Moshera H.
    El-Tamawy, Mohamed S.
    Morsy, Samer
    Abbas, Rami L.
    Ali, Ahmed S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [30] Posterior tibial nerve stimulation as a neuromodulation therapy in treatment of neurogenic overactive bladder in multiple sclerosis: A prospective randomized controlled study
    Marzouk, Mohamed H.
    Darwish, Moshera H.
    El-Tamawy, Mohamed S.
    Morsy, Samer
    Abbas, Rami L.
    Ali, Ahmed S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68